Results for: drugmaker

World's top drugmaker Novartis takes aim at tech

Actavis to spend $66 billion on Allergan

Robin Mulhauser

Sanofi touts new drugs but diabetes outlook disappoints

Pfizer dampens Astra bid hopes with German Merck cancer deal

Sanofi draws up candidate shortlist for top job - source

Sanofi board to meet Tuesday after sacking CEO - sources

Neil Woodford says belief in independent AstraZeneca 'even stronger'

Without CEO, Sanofi touts new drugs in its pipeline

Fast-tracked bill would shield execution drug

Medtronic profit meets expectations Covidien deal on track

Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies

Johann Zarco

AstraZeneca's plans to fend off Pfizer?

Allergan agrees to $66 billion Actavis offer Valeant walks

AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer

Weary of the market rollercoaster, investors turn again to steady stocks

Utah revives plan for executions by firing squad

Ohio panel votes to shield execution drugmaker

Soaring generic drug prices draw Senate scrutiny

Merger fever back on Wall Street